Ligand Pharmaceuticals
LGND
LGND
270 hedge funds and large institutions have $2.18B invested in Ligand Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 111 increasing their positions, 86 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more capital invested
Capital invested by funds: $1.97B → $2.18B (+$213M)
4% more funds holding
Funds holding: 260 → 270 (+10)
2.4% more ownership
Funds ownership: 97.07% → 99.47% (+2.4%)
Holders
270
Holding in Top 10
4
Calls
$1.11M
Puts
$11K
Top Buyers
| 1 | +$36M | |
| 2 | +$11.8M | |
| 3 | +$8.67M | |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$6.62M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.48M |
Top Sellers
| 1 | -$6.99M | |
| 2 | -$5.86M | |
| 3 | -$4.74M | |
| 4 |
LCG
Lisanti Capital Growth
New York
|
-$4.48M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$4.32M |